Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10768390 | Biochemical and Biophysical Research Communications | 2005 | 5 Pages |
Abstract
This study is the first report on the effectiveness and specificity of α-acarviosinyl-(1 â 4)-α-d-glucopyranosyl-(1 â 6)-d-glucopyranosylidene-spiro-thiohydantoin (PTS-G-TH) inhibitor on the 2-chloro-4-nitrophenyl-4-O-β-d-galactopyranosyl-maltoside (GalG2CNP) and amylose hydrolysis catalysed by human salivary α-amylase (HSA). Synthesis of PTS-G-TH was carried out by transglycosylation using acarbose as donor and glucopyranosylidene-spiro-thiohydantoin (G-TH) as acceptor. This new compound was found to be a much more efficient HSA inhibitor than G-TH. The inhibition is a mixed-noncompetitive type on both substrates and only one molecule of inhibitor binds to the enzyme. Kinetic constants calculated from secondary plots are in micromolar range. Values of KEI and KESI are very similar in the presence of GalG2CNP substrate; 0.19 and 0.24 μM, respectively. Significant difference can be found for KEI and KESI using amylose as substrate; 8.45 and 0.5 μM, respectively. These values indicate that inhibition is rather uncompetitive than competitive related to amylose hydrolysis.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Lili Kandra, Ágnes Zajácz, Judit Remenyik, Gyöngyi Gyémánt,